🇺🇸 Hydromorphone ER in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 20
Most-reported reactions
- Decreased Appetite — 2 reports (10%)
- Diarrhoea — 2 reports (10%)
- Dyspnoea — 2 reports (10%)
- Fatigue — 2 reports (10%)
- Glossodynia — 2 reports (10%)
- Hypotension — 2 reports (10%)
- Infection — 2 reports (10%)
- Neuropathy Peripheral — 2 reports (10%)
- Pain — 2 reports (10%)
- Plasma Cell Myeloma — 2 reports (10%)
Other Pain Management approved in United States
Frequently asked questions
Is Hydromorphone ER approved in United States?
Hydromorphone ER does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Hydromorphone ER in United States?
Shirley Ryan AbilityLab is the originator. The local marketing authorisation holder may differ — check the official source linked above.